Research progress on ocular diseases associated with SARS-CoV-2
10.3980/j.issn.1672-5123.2024.6.16
- VernacularTitle:新型冠状病毒相关眼部疾病的研究进展
- Author:
Ying YU
1
;
Zhijian LI
1
Author Information
1. Eye Hospital, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China
- Publication Type:Journal Article
- Keywords:
severe acute respiratory syndrome coronavirus 2(SARS-CoV-2);
angiotensin-converting enzyme-2(ACE2);
transmembrane serine protease 2(TMPRSS2);
ocular diseases
- From:
International Eye Science
2024;24(6):921-924
- CountryChina
- Language:Chinese
-
Abstract:
The corona virus disease 2019(COVID-19)in 2019 has shown a global pandemic status in a short time since its outbreak, and many variants of the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)were highly infectious and pathogenic. SARS-CoV-2 may infect tissue cells through the mediation of angiotensin-converting enzyme-2(ACE2)and transmembrane serine protease 2(TMPRSS2), leading to different diseases. Clinically, respiratory, cardiovascular, and gastrointestinal systems diseases are relatively common; many patients also seek medical attention based on eye symptoms as their main complaint. Compared with severe systemic diseases, eye-related symptoms are easily overlooked. This article reviews the pathogenesis and cases of various eye diseases related to SARS-CoV-2, aiming to enhance clinicians' attention to SARS-CoV-2-related eye diseases, avoid delaying the disease and causing irreversible loss of vision, and provide new ideas for the prevention and treatment of eye diseases.
